These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
429 related articles for article (PubMed ID: 27011217)
1. The oculocerebrorenal syndrome of Lowe: an update. Bökenkamp A; Ludwig M Pediatr Nephrol; 2016 Dec; 31(12):2201-2212. PubMed ID: 27011217 [TBL] [Abstract][Full Text] [Related]
2. Lowe syndrome/Dent-2 disease: A comprehensive review of known and novel aspects. Recker F; Reutter H; Ludwig M J Pediatr Genet; 2013 Jun; 2(2):53-68. PubMed ID: 27625841 [TBL] [Abstract][Full Text] [Related]
3. Complete oculocerebrorenal phenotype of Lowe syndrome in a female patient with half reduction of inositol polyphosphate 5-phosphatase. Yamamoto K; Hasegawa Y; Ohata Y; Satomura K; Mizoguchi Y; Shimotsuji T; Yamamoto T CEN Case Rep; 2020 May; 9(2):95-100. PubMed ID: 31707643 [TBL] [Abstract][Full Text] [Related]
4. OCRL deficiency impairs endolysosomal function in a humanized mouse model for Lowe syndrome and Dent disease. Festa BP; Berquez M; Gassama A; Amrein I; Ismail HM; Samardzija M; Staiano L; Luciani A; Grimm C; Nussbaum RL; De Matteis MA; Dorchies OM; Scapozza L; Wolfer DP; Devuyst O Hum Mol Genet; 2019 Jun; 28(12):1931-1946. PubMed ID: 30590522 [TBL] [Abstract][Full Text] [Related]
5. The 5-phosphatase OCRL in Lowe syndrome and Dent disease 2. De Matteis MA; Staiano L; Emma F; Devuyst O Nat Rev Nephrol; 2017 Aug; 13(8):455-470. PubMed ID: 28669993 [TBL] [Abstract][Full Text] [Related]
7. Characterization of 28 novel patients expands the mutational and phenotypic spectrum of Lowe syndrome. Recker F; Zaniew M; Böckenhauer D; Miglietti N; Bökenkamp A; Moczulska A; Rogowska-Kalisz A; Laube G; Said-Conti V; Kasap-Demir B; Niemirska A; Litwin M; Siteń G; Chrzanowska KH; Krajewska-Walasek M; Sethi SK; Tasic V; Anglani F; Addis M; Wasilewska A; Szczepańska M; Pawlaczyk K; Sikora P; Ludwig M Pediatr Nephrol; 2015 Jun; 30(6):931-43. PubMed ID: 25480730 [TBL] [Abstract][Full Text] [Related]
8. Modeling the neuropsychiatric manifestations of Lowe syndrome using induced pluripotent stem cells: defective F-actin polymerization and WAVE-1 expression in neuronal cells. Barnes J; Salas F; Mokhtari R; Dolstra H; Pedrosa E; Lachman HM Mol Autism; 2018; 9():44. PubMed ID: 30147856 [TBL] [Abstract][Full Text] [Related]
9. Functional Characterization and Rescue of a Deep Intronic Mutation in OCRL Gene Responsible for Lowe Syndrome. Rendu J; Montjean R; Coutton C; Suri M; Chicanne G; Petiot A; Brocard J; Grunwald D; Pietri Rouxel F; Payrastre B; Lunardi J; Dorseuil O; Marty I; Fauré J Hum Mutat; 2017 Feb; 38(2):152-159. PubMed ID: 27790796 [TBL] [Abstract][Full Text] [Related]
10. Novel pathogenic OCRL mutations and genotype-phenotype analysis of Chinese children affected by oculocerebrorenal syndrome: two cases and a literature review. Zhang Y; Deng L; Chen X; Hu Y; Chen Y; Chen K; Zhou J BMC Med Genomics; 2021 Sep; 14(1):219. PubMed ID: 34488756 [TBL] [Abstract][Full Text] [Related]
11. A novel OCRL1 mutation in a patient with the mild phenotype of Lowe syndrome. Sugimoto K; Nishi H; Miyazawa T; Fujita S; Okada M; Takemura T Tohoku J Exp Med; 2014 Mar; 232(3):163-6. PubMed ID: 24614960 [TBL] [Abstract][Full Text] [Related]
12. Renal phenotype in Lowe Syndrome: a selective proximal tubular dysfunction. Bockenhauer D; Bokenkamp A; van't Hoff W; Levtchenko E; Kist-van Holthe JE; Tasic V; Ludwig M Clin J Am Soc Nephrol; 2008 Sep; 3(5):1430-6. PubMed ID: 18480301 [TBL] [Abstract][Full Text] [Related]
13. Kidney Tubular Ablation of Inoue K; Balkin DM; Liu L; Nandez R; Wu Y; Tian X; Wang T; Nussbaum R; De Camilli P; Ishibe S J Am Soc Nephrol; 2017 May; 28(5):1399-1407. PubMed ID: 27895154 [TBL] [Abstract][Full Text] [Related]
14. Lowe syndrome - Case report with a novel mutation in the oculocerebrorenal gene. Sethi S; Sethi N; Mehta S; Kaur S; Makkar V; Sohal PM Saudi J Kidney Dis Transpl; 2020; 31(1):285-288. PubMed ID: 32129227 [TBL] [Abstract][Full Text] [Related]
15. Loss of OCRL increases ciliary PI(4,5)P Prosseda PP; Luo N; Wang B; Alvarado JA; Hu Y; Sun Y J Cell Sci; 2017 Oct; 130(20):3447-3454. PubMed ID: 28871046 [TBL] [Abstract][Full Text] [Related]
16. A premature termination mutation in a patient with Lowe syndrome without congenital cataracts: dropping the "O" in OCRL. Pasternack SM; Böckenhauer D; Refke M; Tasic V; Draaken M; Conrad C; Born M; Betz RC; Reutter H; Ludwig M Klin Padiatr; 2013 Jan; 225(1):29-33. PubMed ID: 22915452 [TBL] [Abstract][Full Text] [Related]
17. Dent-2 disease: a mild variant of Lowe syndrome. Bökenkamp A; Böckenhauer D; Cheong HI; Hoppe B; Tasic V; Unwin R; Ludwig M J Pediatr; 2009 Jul; 155(1):94-9. PubMed ID: 19559295 [TBL] [Abstract][Full Text] [Related]
18. Selective proximal renal tubular involvement and dyslipidemia in two cousins with oculocerebrorenal syndrome of Lowe. Topaloğlu R; Ludwig M; Çelebi Tayfur A Turk J Pediatr; 2013; 55(3):331-4. PubMed ID: 24217083 [TBL] [Abstract][Full Text] [Related]
19. Carrier assessment in families with lowe oculocerebrorenal syndrome: novel mutations in the OCRL1 gene and correlation of direct DNA diagnosis with ocular examination. Röschinger W; Muntau AC; Rudolph G; Roscher AA; Kammerer S Mol Genet Metab; 2000 Mar; 69(3):213-22. PubMed ID: 10767176 [TBL] [Abstract][Full Text] [Related]